Matthew Clemente Chief Technology Officer, Delivery, Devices & Connection Solutions, Eli Lilly & Company

Matthew James Clemente currently serves as the Chief Technology Officer of Delivery, Devices & Connected Solutions at Eli Lilly & Company. He is responsible for the leadership of the design and engineering of an emerging portfolio of electromechanical delivery devices, applications and algorithms that serve a wide variety of therapeutic needs and formulations. He has served in this position since October 2015.

Matt previously served as Director of Advanced Drug Delivery Systems at Unilife Corporation where he built and managed an integrated engineering and science organization focused on mechanical, electromechanical, digital and container closure systems for prefilled, preassembled, wearable drug delivery applications. Prior to Unilife, Matt held a variety of roles of increasing responsibility at multiple Johnson & Johnson companies, where he primarily served in the new product development of insulin pumps at Animas Corporation for J&J’s Diabetes Care Franchise.

By way of education, Matt obtained a Bachelor of Science in Biomedical Engineering from the University of Miami and an MBA in Finance from Villanova University.